Precision BioSciences ($DTIL)

Description

Precision BioSciences develops genome-editing therapies using its ARCUS platform to treat diseases; it runs clinical programs delivering PBGENE investigational medicines for Duchenne muscular dystrophy patients and for people with chronic hepatitis B.

Precision BioSciences ($DTIL) is located in the Research Triangle ecosystem.

Related

• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops gene-based medicines and CRISPR therapies for serious diseases, with programs spanning hemoglobinopathies,…
• Liquidia ($LQDA)Liquidia develops inhaled therapies for rare cardiopulmonary diseases, including pulmonary arterial hypertension, and uses proprietary…
• Bristol Myers Squibb (San Diego)Bristol Myers Squibb (San Diego) researches and develops medicines, conducts clinical-trial research, and offers medicine information,…
• Vertex Pharmaceuticals ($VRTX)Vertex Pharmaceuticals develops and manufactures prescription medicines for people with serious diseases, focusing on therapies used by…
• BioCryst Pharmaceuticals ($BCRX)BioCryst Pharmaceuticals develops and commercializes medicines for rare diseases, focusing on treatments for hereditary angioedema and…
• Humacyte ($HUMA)Humacyte develops and manufactures bioengineered human tissues and organs designed as universally implantable, off-the-shelf regenerative…
• Arsenal BioArsenal Bio develops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity,…
• Precision NeuroscienceDevelops an investigational brain-computer interface intended to let people with paralysis control digital devices through thought, working…
• Locus BiosciencesLocus Biosciences develops engineered bacteriophage precision medicines for bacterial infections, including antibiotic-resistant…